130 related articles for article (PubMed ID: 28203164)
1. Successful Treatment of Advanced Primary Cutaneous Apocrine Carcinoma on the Scrotum with Systemic Chemotherapy and Radiotherapy Followed by Denosumab.
Furudate S; Fujimura T; Tsukada A; Sato Y; Hidaka T; Tanita K; Kambayashi Y; Haga T; Hashimoto A; Aiba S
Case Rep Oncol; 2017; 10(1):52-56. PubMed ID: 28203164
[TBL] [Abstract][Full Text] [Related]
2. The Expression of Matrix Metalloproteinases in Receptor Activator of Nuclear Factor Kappa-B Ligand (RANKL)-expressing Cancer of Apocrine Origin.
Kambayashi Y; Fujimura T; Furudate S; Lyu C; Hidaka T; Kakizaki A; Sato Y; Tanita K; Aiba S
Anticancer Res; 2018 Jan; 38(1):113-120. PubMed ID: 29277763
[TBL] [Abstract][Full Text] [Related]
3. Metastatic cutaneous apocrine adenocarcinoma successfully treated with systemic anti-androgen therapy-A case report.
Collette F; Hamoir M; Van Eeckhout P; D'Abadie P; Duprez T; Schmitz S; Machiels JP
Clin Case Rep; 2020 Dec; 8(12):3472-3478. PubMed ID: 33363954
[TBL] [Abstract][Full Text] [Related]
4. Apocrine carcinoma of the scalp with neck lymph node metastasis: A case report and review of the literature.
Al-Hakami H; Awad BI; Al-Garni M; Al-Maghrabi HA; Al-Shareef N
J Family Med Prim Care; 2019 Nov; 8(11):3758-3762. PubMed ID: 31803688
[TBL] [Abstract][Full Text] [Related]
5. Poorly differentiated cutaneous apocrine carcinomas: histopathological clues and immunohistochemical analysis for the diagnosis of this unusual neoplasm.
Plaza JA; Brenn T; Gru AA; Matoso A; Sheldon J; Sangueza M
Histopathology; 2023 Jan; 82(2):276-284. PubMed ID: 36178027
[TBL] [Abstract][Full Text] [Related]
6. Primary cutaneous apocrine carcinoma arising within a congenital nevus: Keratins and filaggrin expression suggesting differentiation into the secretory cells of apocrine glands.
Senba Y; Kurokawa I; Tokime K; Habe K; Isoda KI; Yamanaka KI; Tsubura A; Mizutani H
Oncol Lett; 2010 May; 1(3):413-416. PubMed ID: 22966317
[TBL] [Abstract][Full Text] [Related]
7. Cutaneous apocrine carcinoma of the scrotum: A case with widespread subcutaneous induration.
Miyagawa T; Kadono T; Taniguchi T; Nakamura K; Saigusa R; Yoshizaki A; Miyagaki T; Yamada D; Masui Y; Sato S
J Dermatol; 2015 Aug; 42(8):815-7. PubMed ID: 25960077
[TBL] [Abstract][Full Text] [Related]
8. Primary cutaneous apocrine carcinoma: 2 cases and review of the pertinent histologic findings.
Schweitzer J; Vermeesch J; Zaleski T; Iacco M; Krach K; Ghaferi J; Cotton J
JAAD Case Rep; 2016 Sep; 2(5):411-414. PubMed ID: 27766305
[No Abstract] [Full Text] [Related]
9. Cutaneous Adnexal Carcinoma with Apocrine Differentiation: A Challenging Diagnosis and Personalized Treatment with mTOR Inhibitor in a Very Rare Disease.
Libertini M; Oneda E; Di Biasi B; Savelli G; Zaniboni A
Case Rep Oncol; 2020; 13(3):1091-1096. PubMed ID: 33082753
[TBL] [Abstract][Full Text] [Related]
10. Management of Metastatic Apocrine Hidradenocarcinoma with Chemotherapy and Radiation.
Miller DH; Peterson JL; Buskirk SJ; Vallow LA; Ta R; Joseph R; Krishna M; Ko SJ; Tzou KS
Rare Tumors; 2015 Sep; 7(3):6082. PubMed ID: 26500736
[TBL] [Abstract][Full Text] [Related]
11. Primary Cutaneous Apocrine Carcinoma of the Thigh: A Rare Case Report.
Bouabid M; BenSghier A; Moukhlissi M; Berhili S; Mezouar L
Cureus; 2024 Apr; 16(4):e57859. PubMed ID: 38721194
[TBL] [Abstract][Full Text] [Related]
12. Denosumab treatment of inoperable or locally advanced giant cell tumor of bone.
Borkowska A; Goryń T; Pieńkowski A; Wągrodzki M; Jagiełło-Wieczorek E; Rogala P; Szacht M; Rutkowski P
Oncol Lett; 2016 Dec; 12(6):4312-4318. PubMed ID: 28101196
[TBL] [Abstract][Full Text] [Related]
13. Roles of the RANKL-RANK axis in antitumour immunity - implications for therapy.
Ahern E; Smyth MJ; Dougall WC; Teng MWL
Nat Rev Clin Oncol; 2018 Nov; 15(11):676-693. PubMed ID: 30232468
[TBL] [Abstract][Full Text] [Related]
14. Recurrent apocrine carcinoma of the scrotum: a case report.
Campobasso D; Thai E; Barbieri A; Ziglioli F; Maestroni U; Fellegara G; Ricci R
Pathol Res Pract; 2015 Mar; 211(3):264-7. PubMed ID: 25596997
[TBL] [Abstract][Full Text] [Related]
15. Primary apocrine carcinoma of scalp: report of primary scalp cutaneous apocrine carcinoma indistinguishable from cutaneous metastasis of breast carcinoma.
Kim HK; Chung KI; Park BY; Bae TH; Kim WS; Lee TJ
J Plast Reconstr Aesthet Surg; 2012 Mar; 65(3):e67-70. PubMed ID: 22122891
[TBL] [Abstract][Full Text] [Related]
16. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study.
Bradley JD; Paulus R; Komaki R; Masters G; Blumenschein G; Schild S; Bogart J; Hu C; Forster K; Magliocco A; Kavadi V; Garces YI; Narayan S; Iyengar P; Robinson C; Wynn RB; Koprowski C; Meng J; Beitler J; Gaur R; Curran W; Choy H
Lancet Oncol; 2015 Feb; 16(2):187-99. PubMed ID: 25601342
[TBL] [Abstract][Full Text] [Related]
17. Primary cutaneous cribriform apocrine carcinoma: Case report and literature review.
Wu JD; Changchien CH; Liao KS
Indian J Dermatol Venereol Leprol; 2018; 84(5):569-572. PubMed ID: 29735815
[TBL] [Abstract][Full Text] [Related]
18. The anti-tumor effect of RANKL inhibition in malignant solid tumors - A systematic review.
de Groot AF; Appelman-Dijkstra NM; van der Burg SH; Kroep JR
Cancer Treat Rev; 2018 Jan; 62():18-28. PubMed ID: 29154022
[TBL] [Abstract][Full Text] [Related]
19. Sustained long-term complete regression of a giant cell tumor of the spine after treatment with denosumab.
Mattei TA; Ramos E; Rehman AA; Shaw A; Patel SR; Mendel E
Spine J; 2014 Jul; 14(7):e15-21. PubMed ID: 24534393
[TBL] [Abstract][Full Text] [Related]
20. Expression Profiling of Receptor-Activator of Nuclear Factor-Kappa B Ligand in Soft Tissue Tumors.
Yamagishi T; Kawashima H; Ogose A; Ariizumi T; Oike N; Sasaki T; Hatano H; Ohashi R; Umezu H; Ajioka Y; Endo N
Tohoku J Exp Med; 2019 Jun; 248(2):87-97. PubMed ID: 31189751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
